Article
IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Oct 2009
Nobusawa Sumihito, Watanabe Takuya, Kleihues Paul, Ohgaki Hiroko
Abstract excerpt
PURPOSE: To establish the frequency of IDH1 mutations in glioblastomas at a population level, and to assess whether they allow reliable discrimination between primary (de novo) glioblastomas and secondary glioblastomas that progressed from low-grade or anaplastic astrocytoma. EXPERIMENTAL DESIGN: We screened glioblastomas from a population-based study for IDH1 mutations and correlated them with clinical data and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
